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Abstract
■ Genetics and neuroscience are two areas of science that pose
particular methodological problems because they involve de-
tecting weak signals (i.e., small effects) in noisy data. In recent
years, increasing numbers of studies have attempted to bridge
these disciplines by looking for genetic factors associated with
individual differences in behavior, cognition, and brain structure
or function. However, different methodological approaches to
guarding against false positives have evolved in the two disci-
plines. To explore methodological issues affecting neurogenetic
studies, we conducted an in-depth analysis of 30 consecutive ar-
ticles in 12 top neuroscience journals that reported on genetic
associations in nonclinical human samples. It was often difficult
to estimate effect sizes in neuroimaging paradigms. Where effect
sizes could be calculated, the studies reporting the largest effect
sizes tended to have two features: (i) they had the smallest sam-
ples and were generally underpowered to detect genetic effects,
and (ii) they did not fully correct for multiple comparisons. Fur-
thermore, only a minority of studies used statistical methods for
multiple comparisons that took into account correlations be-
tween phenotypes or genotypes, and only nine studies included
a replication sample or explicitly set out to replicate a prior find-
ing. Finally, presentation of methodological information was not
standardized and was often distributed across Methods sections
and Supplementary Material, making it challenging to assemble
basic information from many studies. Space limits imposed by
journals could mean that highly complex statistical methods
were described in only a superficial fashion. In summary,
methods that have become standard in the genetics litera-
ture—stringent statistical standards, use of large samples, and
replication of findings—are not always adopted when behav-
ioral, cognitive, or neuroimaging phenotypes are used, leading
to an increased risk of false-positive findings. Studies need to
correct not just for the number of phenotypes collected but also
for the number of genotypes examined, genetic models tested,
and subsamples investigated. The field would benefit frommore
widespread use of methods that take into account correlations
between the factors corrected for, such as spectral decomposi-
tion, or permutation approaches. Replication should become
standard practice; this, together with the need for larger sample
sizes, will entail greater emphasis on collaboration between re-
search groups. We conclude with some specific suggestions for
standardized reporting in this area. ■
INTRODUCTION
Studies reporting associations in humans between com-
mon genetic variants and brain structure or function are
burgeoning (Bigos, Hariri, & Weinberger, 2016). One rea-
son is the desire to find “endophenotypes” that provide
an intermediate step between genetic variants and behav-
ior (Flint & Munafò, 2007); to this end, it is often as-
sumed that brain-based measures will give stronger
associations than observed behavior because they are
closer to the gene function. Furthermore, it is now
cheaper and easier than ever before to genotype individ-
uals, with many commercial laboratories offering this ser-
vice, so neuroscientists interested in pursuing genetic
studies need not have their own laboratory facilities to
do this. The ease of undertaking genetic association stud-
ies is, however, offset by methodological problems that
arise from the size and complexity of genetic data. As
Poldrack et al. (2017, p. 115) cautioned with regard to
neuroimaging data, “the high dimensionality of fMRI data,
the relatively low power of most fMRI studies and the
great amount of flexibility in data analysis contribute to a
potentially high degree of false-positive findings.” When
genetic approaches are combined with neuroscience
methods, these problems are multiplied. Two issues are
of particular concern.
The first issue is that the field of neuroscience is char-
acterized by low statistical power (Button et al., 2013),
where sample sizes are often too small to reliably detect
effects of interest. Underpowered studies are likely to
miss true effects, and where “significant” effects are
found, they are more likely to be false positives. Where
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common variants are associated with behavioral pheno-
types, effect sizes are typically very small; robust associa-
tions identified in genome-wide association studies
(GWAS) typically account for less than 0.1% of pheno-
typic variance (Flint & Munafò, 2013). These reach
genome-wide significance only when very large samples
are used with this method. If we have a single-nucleotide
polymorphism (SNP) where a genetic variant accounts
for 0.1% of variance (i.e., r2 = .001) and we want to
reliably detect an association of that magnitude, simple
power calculations (Champely, 2016) show that we
would need a total sample of 780 cases to detect the effect
with 80% power at the .05 level of significance. If we had
200 participants (100 for each of two genotypes), then our
power to detect this effect would be only 29%. Although it is
often argued that effect sizes for neuroimaging phenotypes
may be larger than for behavioralmeasures, a recent analysis
by Poldrack et al. (2017) suggests caution. They found that,
for a motor task that gives relatively large and reliable
activation changes in the precentral gyrus, 75% of the
voxels in that region showed a standardized effect size
(Cohen’s d) of less than one, and the median effect size
was around .7; for other well-established cognitive
tasks, the median effect sizes for a specified ROI
ranged from .4 to .7. Furthermore, these effect sizes
reflect within-subject comparisons of the overall acti-
vation of task versus baseline: When assessing differ-
ences in activation between groups, effect sizes can be
expected to be smaller than this.
The second issue is that problems arise when there is a
failure to appreciate that p values are only interpretable
in the context of a hypothesis testing study (de Groot,
2014). Our knowledge is still limited, and many studies
in this area are exploratory: Insofar as there is a hypoth-
esis, it is often quite general, namely, that there may be a
significant association between one of the genotypes ex-
amined and one or more phenotypes. Spurious findings
are likely if there are many possible ways of analyzing
findings, and the measures or analyses are determined
only after inspecting the data (Vul & Pashler, 2012). This
leads to the twin problems of p hacking (selecting and
modifying analyses until a “significant” p value is found)
and hypothesizing after results are known (Kerr, 1998),
both of which render p values meaningless. These prac-
tices are common but not easy to detect, although they
may be suspected when there are numerous p values just
below a “significance” threshold (Simonsohn, Simmons,
& Nelson, 2015), or when the selection of measures or
analyses has no obvious justification. One solution is to
adopt a two-stage approach, where an association ob-
served in an initial exploratory study (the “discovery”
sample) is then tested in a more focused study that aims
to replicate the salient findings in a fresh sample (the
“replication” sample). This approach is now common in
GWAS, after early association studies were found to pro-
duce numerous false-positive findings. Before the advent
of GWAS, the majority of reported associations did not
replicate consistently (Sullivan, 2007). Most genetics jour-
nals now require that, to be published, associations have
to be replicated (e.g., Behavior Genetics; Hewitt, 2012),
and researchers have learned that large samples are
needed to obtain adequate statistical power for rep-
lication (Lalouel & Rohrwasser, 2002) because initial
reports overestimate true effect size. However, outside
of GWAS, the importance of adequately powered repli-
cation is not always appreciated. As Poldrack et al. (2017,
p. 117) noted, imaging genetics is “a burgeoning field
that has yet to embrace the standards commonly followed
in the broader genetics literature.”
An alternative approach to replication is to perform a sta-
tistical correction for the number of comparisons in an
analysis. However, for this to be effective, the adjustment
must be made for the multiplicity of potential analyses at
several levels. Consider, for instance, a study where three
SNPs are studied for association with measures of neural
connectivity based on four brain regions. If the SNPs are
in linkage equilibrium (i.e., not associated) and the connec-
tivity measures are uncorrelated, then it might seem that
we could adequately control Type I error by using a
Bonferroni-corrected p value of .05/(3 × 4) = .004. How-
ever, suppose the researchers also study connectivity
between brain regions, then there are six measures to
consider (AB, AC, AD, BC, BD, CD). They may go on to
test two models of genetic association (dominant and
recessive) and further subdivide the sample by sex, increas-
ing the number of potential comparisons to 3 × 6 × 2 ×
2 = 72 and the Bonferroni-corrected p value to .0007.
Furthermore, we cannot compute this probability cor-
rectly unless all conducted tests are reported: If the
authors remove reference to SNPs, genetic models, sub-
groups, or phenotypes that did not yield significant
results, then reported p values will be misleading. In
GWAS, the finite search space (essentially the likely
number of functional genetic variants in the human ge-
nome, estimated as around one million) means that a
p value threshold corrected for all possible tests can be
calculated—in these studies, genome-wide significance
for a single trait is typically set at 5 × 10−8 (Sham &
Purcell, 2014).
Journal editors are becoming aware of problems of
reproducibility in the field of neuroscience (Nicolas,
Charbonnier, & Oliveira, 2015), many of which are rem-
iniscent of earlier problems in the candidate gene era
(Flint, Greenspan, & Kendler, 2010). The current study
was designed to evaluate the extent to which these prob-
lems currently affect the field of human neurogenetics
and to identify instances of good practice that might sug-
gest ways of overcoming the methodological and logical
difficulties that researchers in this area face.
STUDY PROTOCOL
The protocol for this study was registered on Open Sci-
ence Framework (osf.io/67jwb/). Many modifications
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were subsequently made in the course of collating stud-
ies for analysis, because articles or reported measures did
not readily fit into the categories we had anticipated.
Furthermore, the complexity of the methods used in many
studies was such that it took substantial time to identify
basic information such as effect sizes, which led to us
focusing on a more restricted set of study features than
we had originally planned. In addition, we added Cyril
Pernet to the study team, as it became clear that we
needed additional expertise in neuroimaging methods to
evaluate some of the articles. Departures from the protocol
are noted below, with an explanation of each one.
Electronic Search Strategy
The search was conducted using the Web of Science da-
tabase. We started with the 20 most highly ranked jour-
nals in neuroscience and behavior (source: https://www.
timeshighereducation.com/news/top-20-journals-in-
neuroscience-and-behaviour/412992.article). We then
excluded journals that have a wide scope of subject
matter (e.g., Nature, Proceedings of the National Acad-
emy of Sciences) and those that focus on review articles
(e.g., Current Opinion in Neurobiology), which left
12 suitable journals to be used for the literature search.
All of these publish articles in English only.
In our protocol, we planned to examine 50 publica-
tions, but we had underestimated the amount of time
needed to extract information from articles, many of
which were highly complex. When this became apparent,
we decided that our resources would allow us to examine
30 publications in full, and so we restricted consideration
to the most recent articles, starting with June 2016 and
working backwards until 30 suitable articles were
selected (initial search June 2016 to June 2011).
To identify relevant articles, the names of the 12 jour-
nals were coupled with topic-specific search terms. We
limited the search to studies of humans and used the
following key terms:
(Nature Neuroscience OR Neuron OR Annals of Neu-
rology OR Brain OR Molecular Psychiatry OR Biologi-
cal Psychiatry OR Journal of Neuroscience OR
Neurology OR Journal of Cognitive Neuroscience OR
Pain OR Cerebral Cortex OR Neurolmage) AND TOPIC:
(genetic OR gene OR allele) AND TOPIC: (association)
AND TOPIC: (cognition OR behaviour OR individual
differences OR endophenotype) AND TOPIC: (human)
Selection Criteria and Data Extraction
The first author screened abstracts found by the electro-
nic search to identify relevant articles. The first and last
author independently coded the first 500 articles and dis-
cussed sources of disagreement. This led to some refine-
ment of the inclusion and exclusion criteria that had been
specified in the original protocol, as described below (see
Figure 1). The first 30 articles that met the final inclusion
and exclusion criteria were fully reviewed, and metadata
were extracted (see below for details).
Inclusion Criteria
• Candidate gene(s) study.
• Studies predominantly focusing on healthy individ-
uals. This includes population-based studies that
may include individuals suffering from a disorder
but where the phenotype of interest is a cognitive,
behavioral, or neuroimaging characteristic.
Exclusion Criteria
Original exclusion criteria specified in our protocol were
as follows:
• review articles;
• GWAS;
• studies predominantly focusing on genetic associa-
tions where the phenotype is a disease or disorder
(e.g., neurodegenerative disease, neurodevelopmen-
tal disorder, or psychiatric disorders).
Additional exclusionary criteria included after assem-
bling the pool of potential studies:
• studies reporting an abstract only;
• studies solely on nonhuman species;
• studies solely focused on rare variants (i.e., those with
a minor allele frequency less than 1%, or copy number
variants), because our focus was on common variation
rather than disease, and rare variants and copy num-
ber variants require a different analytic approach;
Figure 1. Flowchart showing stages of article selection.
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• studies focused solely on gene expression;
• studies with no molecular genetic content (e.g., twin
studies);
• analyses using polygenic risk scores.
Data were extracted for the following characteristics:
1. Information about the study sample (the aim was to
record information that made it possible to judge
whether this was a clinical or general population
sample, and if general population, whether a conve-
nience sample or more representative);
2. all SNPs that were tested;
3. all measures of cognition, behavior, or neurological
structure or function that were used as dependent
variables;
4. sample size;
5. analysis method(s);
6. any results given in terms of means and variance (SD or
SE) on dependent measures in relation to genotype;
7. statistics that could be used to obtain a measure of
association (odds ratios, regression coefficients,
p values, etc.).
In our original protocol, we had planned also to evalu-
ate the functionality of polymorphisms, to look for infor-
mation on the reliability of phenotypes, and to evaluate
the comprehensiveness of the literature review of each
study, but the challenges we experienced in extracting
and interpreting statistical aspects of the main results
meant that we did not have sufficient resources to do
this.
The information that we extracted was used to popu-
late an Excel template for each study, which included in-
formation on sample size, corrections for multiple
comparisons, and whether or not a replication sample
was included. The sample size was used to compute
two indices of statistical power using the pwr package
in R (R Core Team, 2016): (i) the effect size (r) detectable
with 80% power and (ii) the power of the study to detect
an effect size (r) of .1.
We planned also to extract an effect size for each study,
indicating the strength of genetic influence on the phe-
notype of interest. This proved difficult because many
studies reported a complex range of results, with some
including interaction effects as well as main effects of
genotype. In addition, for studies reporting neuroimag-
ing results, large amounts of data with spatial and tempo-
ral dependencies pose considerable challenges when
estimating effect sizes, and so such studies were flagged
as they often required alternative approaches.
To make the task of synthesizing evidence more trac-
table, we identified a “selected result” for each study. To
facilitate comparisons across studies and avoid the need
for subjective judgment about the importance of differ-
ent results, we identified this as the genotypic effect with
the largest effect size (excluding any results from nonhu-
man species): This means that our estimates of study
power give a “best case scenario.” It also meant that, in
our summary template, study findings were often over-
simplified, but we included a “comments” field that
allowed us to describe how this selected result fitted into
the fuller context of the study. Our approach to comput-
ing a standard effect size is detailed below in the section
on Analytic Approach.
In a further departure from our original protocol, we
sent the template for each study to the first and last au-
thors with a request that they scrutinize it and correct any
errors, with a reminder sent 2–3 weeks later to those who
had not responded. Acknowledgement of the email was
obtained from authors of 23 of 30 studies (77%), 19 of
whom (63%) provided the requested information, either
confirming the details in the template or making sugges-
tions or corrections. The latter were taken into consider-
ation in the summary of each study. We initially referred
to the selected result with the largest genetic effect as a
“key result,” and several authors were unhappy with this,
as they felt that we should focus on the result of greatest
interest, rather than largest effect size. We dealt with this
by rewording and adding further explanation about other
results in the study, noting when the selected result did
not correspond to the author’s main focus.
Simulations
We had not planned to include simulations in our proto-
col, but we found it helpful to write scripts to simulate
data to explore two issues that arose. First, we consid-
ered how the false-positive rate was affected when all
three models (additive, dominant, and recessive) were
tested in the same data set. Second, we considered
how the use of a selected sample (e.g., high-ability stu-
dents) might affect genetic associations when cognitive
phenotypes were used.
Effect Size Estimation
For each study, we aimed to extract an effect size, repre-
senting the largest reported effect of a genotype on a
phenotype. For simple behavioral/cognitive phenotypes,
it was usually possible to compute an effect size in terms
of the correlation coefficient r, which when squared pro-
vides the proportion of variance accounted for by geno-
type. The correlation coefficient is identical to the
regression coefficient β, when both predicted variable
( y = phenotype of interest) and predictor (x = geno-
type) are standardized. For a standard additive genetic
model with three genotypes (aa, aA, and AA), the num-
ber of “risk” alleles is the independent measure, so the
regression tests for a linear increase in phenotypic score
from aa to aA to AA. Where authors reported an unstan-
dardized regression coefficient, b, the correlation coeffi-
cient r was obtained by the formula r = b.sx/sy, where sx
and sy are the standard deviation for x (N risk alleles) and
y (phenotype). Formulae from Borenstein, Hedges,
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Higgins, and Rothstein (2009) were used to derive values
of r when data were reported in terms of Cohen’s d, odds
ratios, or means and standard deviations by genotype.
Where standard errors were reported, these were
converted to standard deviations by the formula SD =
SE × sqrt(N).
Two studies used structural equation modeling of rela-
tionships between variables, demonstrating that model fit
was improved when genotype was incorporated in the
model. In these cases, standardized parameter estimates
or Pearson correlation coefficients relating genotype to
phenotype were used to provide a direct measure of
effect size (r).
For studies using phenotypic measures based on neu-
roimaging, an effect size can be estimated if an average
measure of structure (e.g., gray or white matter volume)
or function (e.g., BOLD response) was taken from a brain
region that was predefined in a way that was independent
of the genetic contrast. For instance, the focus may be on
a region that gave a significant group difference in a pri-
or study or the region may be chosen because it reliably
gives strong activation on a task of interest. If several
such regions are identified, then it is necessary to cor-
rect for multiple testing (see below), but the measure
can be treated like any other phenotype when comput-
ing a standardized effect size, for example, using the
slope of the regression for three genotype groups in
an additive model to quantify how much variance in
the neuroimaging measure is accounted for by genetic
differences.
Few neuroimaging studies, however, adopted that ap-
proach. More commonly, they reported peak voxel statis-
tics. This involves a statistical approach of searching for
the voxel or cluster of voxels that gives the strongest ef-
fect, sometimes in a confined ROI, sometimes over many
brain regions, and sometimes over the whole brain. The
search volume can consist of tens or even hundreds of
thousands of voxels. It is well recognized in this field that
correction of alpha levels needs to be made to control
the rate of false positives, and a range of methods has
been developed for this purpose.1
Although these methods make it possible to identify
patterns of neural structure or function that differ reliably
between groups, it is still not possible to derive a mean-
ingful measure of effect size. This is because the focus is
on just the subset of voxels that reached significance. As
Reddan, Lindquist, and Wager (2017) put it, “It is like a
mediocre golfer who plays 5,000 holes over the course
of his career but only reports his 10 best holes. Bias is
introduced because the best performance, selected
post hoc, is not representative of expected performance.”
In addition, the extent of the overestimate will depend
on study-specific variables, such as the number of voxels
considered and the size of clusters. Estimates of effects
will also be distorted because of spurious dependencies
in the data between true effects and noise (Kriegeskorte,
Simmons, Bellgowan, & Baker, 2009). These problems
are compounded by two further considerations. First,
groups in genetic analyses are often unequal in size;
where the dependent measure represents peak activa-
tion, the group with the biggest sample size and/or
smaller variance in space will have a greater impact on
the results. To continue the golfing analogy, if we com-
pared two golfers on the basis of their best 10 games and
one had played 100 games and the other only 20, then
the one with the more games would look better, even
if in fact there was no difference in skill.
It is not uncommon for researchers to use measures of
peak activation but treat the resulting measures like more
classic dependent variables (e.g., graphing means and
standard errors for measures of activation across genetic
groups and reporting these along with corrected
p values). Such estimates are inaccurate and possibly in-
flated, yet often these are the only kind of data available.
Accordingly, where such approaches were adopted, we
used the reported data to derive a “quasi-effect size,” de-
riving r from means and standard deviations, but we
treated these separately from other effect sizes, as they
are likely to be distorted, and it is not possible to esti-
mate by how much.
Analytic Approach
Our analysis was predominantly descriptive and involved
documenting the methodological characteristics of the
30 studies. In addition, we considered how effect size re-
lated to statistical power and the methods used to correct
for multiple comparisons.
RESULTS
The genes and phenotypes that were the focus of each
study are shown in Appendix 1, and full summary find-
ings for each of the 30 studies are shown in Appendix 2
(both available via Open Science Framework: osf.io/
pex6w). These are based on the templates that were sent
to the authors of the articles, but they have been modi-
fied on the basis of further scrutiny of the studies. In a
preliminary check, we compared these articles to the set
of 548 studies from the Neurosynth database that had been
used by Poldrack et al. (2017) to document trends in sam-
ple size for neuroimaging articles between 2011 and 2015.
There was no overlap between the two sets.
Effect Size of Selected Result in Relation to
Sample Size
All the studies under consideration reported p values, but
only four explicitly reported conventional effect sizes
(one as Cohen’s d and three as regression coefficients).
Some fMRI studies mentioned “effect size” or “size of
effect” when referring to brain activation, but this was
on an arbitrary scale and therefore difficult to interpret.
Nevertheless, we were able to compute an effect size from
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reported statistics for all studies that used behavioral (in-
cluding cognitive) phenotypes and quasi-effect size (see
above) for eight studies using neuroimaging phenotypes.
As noted, effect sizes of common genetic variants on
behavioral or neurological phenotypes are typically small
in magnitude. Where a research literature includes un-
derpowered studies, effect size may be negatively corre-
lated with sample size, reflecting the fact that small
effects do not reach statistical significance in small sam-
ples and tend not to be published. This effect was appar-
ent in the 30 articles included in our review. The relevant
data are shown in Figure 2, where r is plotted against log
sample size. Quasi-effect sizes from neuroimaging studies
are likely to be inflated, and so these are shown using
different symbols.
The correlation between effect size and log sample size
is −.85 (bootstrapped 95% CI [−.68, .94]) for the whole
sample and −.77 (bootstrapped 95% CI [−.38, −.94])
when 10 neuroimaging studies with quasi-effect sizes
are excluded. It is clear from inspection that effect sizes
(r) greater than .3 are seen only in studies where the total
sample size is 300 or less. Only one study with a sample
size of 500 or more obtained an effect size of greater than
.2. The largest reported effect size mostly clustered
around the line corresponding to the effect detectable
with 80% power: This makes sense insofar as studies
are published only if they report statistically significant
results. Thus, it is not that smaller studies show larger
effects, but rather than in smaller studies, small effects
would not be statistically significant and so would tend
to go unreported.
Corrections for Multiple Comparisons
The need to take multiple comparisons into account ap-
pears to be generally recognized: 23 of the 30 studies
(77%) made some mention of this, although they varied
widely in how they handled this issue. We had originally
intended to simply report the number and nature of cor-
rections used for multiple comparisons. However, this
too proved complicated because there were many ways
in which analytic flexibility could be manifest, with multi-
ple comparison issues arising at several levels: in terms of
analysis of subsamples, number of genetic models, num-
ber of polymorphisms, number of phenotypes, and, for
neuroimaging studies, number of brain regions consid-
ered. In Table 1, we show for each study the numbers
of comparisons at each level, as well as “All Compari-
sons,” which is the product of these. Matters are more
complicated when there are dependencies between var-
iables of a given type, as discussed in more detail below.
Furthermore, it could sometimes be difficult to summa-
rize the information, if certain phenotypes were assessed
for just a subset of the sample or were ambiguous as to
whether they were phenotypes or moderators. In what
follows, we first discuss multiplicity in terms of sub-
groups, then at genetic and phenotypic levels, before
finally considering multiple comparisons in the context
of neuroimaging studies.
Subgroups
In subgroup analysis, the association between genotype
and phenotype is conducted separately for each sub-
group (e.g., male and female). Typically, this is in addi-
tion to analysis of the whole sample with all subgroups
included. Subgroup analysis is different from replication,
where an association discovered in one sample is then
confirmed in another, independent sample (see below).
Most studies did not conduct any subgroup analysis, but
four subdivided the participants by sex, one by ethnic
group, one by age band, and one by psychiatric disorder
in relatives.
It is well known that deciding to analyze subgroups
after looking at the data inflates Type I error (Naggara,
Raymond, Guilbert, & Altman, 2011), but there may be
good a priori reasons for distinguishing subgroups. Sub-
sampling by sex is justified where a relevant polymor-
phism is located on a sex chromosome or where there
are sex differences in the phenotype. Subsampling by
ethnicity is generally advised to avoid spurious associa-
tions arising because of different proportions of polymor-
phisms in different ancestral groups (Tang et al., 2005)—
known as population stratification. Nevertheless, subsam-
ples will be smaller than combined samples, so power of
the analysis is reduced, and furthermore, each subsample
included in an analysis will increase the likelihood of
Type I error unless the alpha level is controlled. Only
two of the seven studies of subgroups made any adjust-
ment for the number of subgroups.
Genetic Variation
For the genotype part of genotype–phenotype associa-
tion, there are two factors to take into account: (a) the
number of polymorphisms considered and (b) the num-
ber of genetic models tested.
Figure 2. Largest obtained effect size in relation to sample size (on log
scale). Quasi-effect sizes (see text) shown as unfilled symbols. The red
dotted line shows smallest effect size detectable with 80% power.
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Number of polymorphisms. Polymorphisms are seg-
ments of DNA that take different forms in different peo-
ple.2 Most studies in our analysis investigated how
phenotypes related to variation in one or more SNPs,
with the number of SNPs ranging from 1 to 192.
Correlation between alleles at two or more genetic loci
is referred to as linkage disequilibrium. This can arise
when loci are close together on a chromosome and so
not separated by recombination events during meiosis,
or it may be a consequence of population stratification,
for example, if certain genotypes are correlated with eth-
nicity or if there is assortative mating. Genetic variants
that are inherited together on the same chromosome
(i.e., from the same parent) give rise to combinations
of alleles known as haplotypes. Rather than studying
SNPs, some studies categorized participants according
to haplotype status; this involves looking at the sequence
of DNA in longer stretches of DNA, taking parent of
origin into account.
Where polymorphisms are independent, a Bonferroni
correction may be used by simply dividing the critical
p value by the number of SNPs (Clarke et al., 2011).
For polymorphisms in linkage disequilibrium, the
Bonferroni correction is overly conservative. A range of
methods has been developed to handle this situation,
and some of these are routinely output from genetic anal-
ysis software. For instance, the dimensionality of the data
may be reduced by spectral decomposition or by basing
analysis on haplotype blocks rather than individual SNPs:
These methods of data reduction are often incorporated
as an additional step of correction for the effective num-
ber of comparisons once the dimensionality has been
reduced. Clarke et al. (2011) noted that permutation
methods are often regarded as the gold standard for cor-
recting for multiple testing, but they are computationally
intensive. Table 2 shows the different methods encoun-
tered in the 13 studies that reported analysis of more
than one polymorphism. It is clear there is a wide varia-
tion in the types of correction that are used, and some
studies do not report any correction despite studying
two or more independent genotypes. Furthermore, cor-
relations between polymorphisms were not always re-
ported: In such cases, it was assumed they were
uncorrelated.
The majority of studies (n = 17) did not require any
correction as only one SNP was reported. It is, of course,
not possible to tell whether researchers tested a larger
number of variants and selectively reported only those
that reached statistical significance. A problem for the
field is that it is difficult to detect this practice on the ba-
sis of published results. We know that dropping nonsig-
nificant findings is a common practice in psychology
(John, Loewenstein, & Prelec, 2012), and we may suspect
selective reporting in studies where the choice of SNP
seems arbitrary and unrelated to prior literature. We note
below that requiring authors to report explicitly on
whether all conducted tests were reported would
ameliorate the situation. Furthermore, study preregistra-
tion will remove uncertainty about which analyses were
planned.
Eleven of the 13 studies that reported on two or more
SNPs corrected for the number of genotypes tested,
though two studies appeared to overcorrect, by using a
Bonferroni correction for correlated SNPs. The remaining
studies used a range of approaches, some of which pro-
vided useful examples of how to deal effectively with the
issue of multiple testing, as described further in the
Discussion.
Genetic models. Consider a polymorphic SNP, with a
major (more common) allele A and a minor (less com-
mon) allele a, giving three possible genotypes, AA, Aa,
and aa. Let us suppose that A is the risk allele (i.e., asso-
ciated with less optimal phenotype). There are three
models of genetic association that are commonly tested:
(i) additive model, tested by assessing the linear regres-
sion of phenotype on number of copies of allele A; (ii) a
dominant effect, where aa differs from AA and Aa, with
no difference between the latter two genotypes; and (iii)
a recessive effect, where AA differs from Aa and aa (see
Figure 3).
Some studies considered all three types of model,
whereas others tested just one type of model. In other
cases, the comparison was between two genotypes that
corresponded to groups identified by the length of tan-
dem repeats, rather than base changes, and in one case a
polymorphism on the X chromosome was considered in
men, which gave a two-group comparison (Base A vs.
Base G)—because men have only one X chromosome.
There was only one study that explicitly tested three
genetic models for each of several SNPs (additive,
dominant, and recessive), and that study included a
Bonferroni correction to adjust for this. This is, in fact,
overly conservative, as the predictions of an additive
model partially overlap with those of recessive and dom-
inant models. We devised a simulation to evaluate this sit-
uation. The phenotype was modeled as a random normal
Table 2. Correction for Multiple Testing in Relation to Genetic
Variants Considered: 13 Studies with Two or More
Polymorphisms
Correlateda
Polymorphisms
Uncorrelated
Polymorphisms
No 0 2
Bonferroni 2 2
Data reductionb 3 0
Permutation 2 1
aTreated as correlated if authors reported greater than chance associa-
tion between SNPs.
bFor example, using spectral decomposition to reduce dimensionality
of data or haplotype analysis.
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deviate, unrelated to simulated alleles at two loci for an
SNP (A or a), so odds of obtaining a p value of <.05 for
any one analysis should be 1 in 20. Regression analyses
were run to look for an effect of number of A alleles (ad-
ditive model), the effect of AA + Aa versus aa (dominant
model), and the effect of AA versus Aa + aa (recessive
model). Results indicated that adequate control for multi-
ple comparisons is obtained by dividing the p value by
two (Figure 4). One study focused on interactions be-
tween two loci (epistasis) rather than main effects. Of
the 28 remaining studies reporting just one genetic
contrast per polymorphism, 17 reported results from ad-
ditive genetic models (contrasting those with zero, one,
or two copies of an allele), nine reported only nonadditive
(dominant or recessive) models, and two included a
mixture of additive and nonadditive models, depending
on the SNP. Of those reporting nonadditive models, some
justified the choice of model by reference to previous
studies, but others grouped together heterozygotes and
homozygotes with the minor allele for convenience
because the latter group was too small to stand alone.
Phenotypes
Phenotypes included measures of cognition, behavior,
psychiatric, or brain functioning. For neuroimaging stud-
ies, the phenotypes included measures of brain structure
or activation in response to a task. As described more
fully below, the neuroimaging literature has developed
particular strategies for dealing with the multiple con-
trasts issue; in Table 1, the number of brain regions is ig-
nored when documenting the number of phenotypes.
However, if brain activation was measured in several dif-
ferent tasks, then each task corresponded to a phenotype
as defined for our purposes.
The simplest situation was where a phenotype was as-
sessed using a behavioral or cognitive test that yielded a
single measure, but this type of study was rare. Multiple
phenotypic measures were common. As with genotypes,
these were frequently correlated with one another, mak-
ing Bonferroni correction too conservative, but studies
often failed to report the extent of correlation between
phenotypes. Often multiple measures were used to test
the same construct, and so it is to be expected they
would be intercorrelated: In such cases, if no mention
is made of extent of intercorrelation, we record the cor-
relation as “unclear” in Tables 1 and 3. There was wide
variation in the corrections used for the number of phe-
notypes. No correction was reported for 11 of 19 studies
(58%) that included two or more phenotypes (see
Table 3). In all cases, the phenotypes were correlated
(or probably correlated)—thus, conventional Bonferroni
correction would have been too stringent.
Of the four studies using Bonferroni correction, three
had correlated phenotypes, but one (Study 9) took into
account correlation between variables by reducing the
denominator in the correction, though in what appeared
to be an arbitrary fashion. More complex methods using
permutation or bootstrapping were used in only three
studies.
Neuroimaging Phenotypes
In neurogenetics, the goal is to find structural or functional
correlates of genotypes. It has long been recognized that
neuroimaging poses multiple comparison problems of its
Figure 3. Schematic of three
types of genetic model.
Figure 4. Simulated data showing proportions of significant ( p < .05)
runs of a simulation that tests for all three genetic models when null
hypothesis is true. The total region of the pie corresponds to 10% of all
runs (i.e., twice the expected 5%, but lower than the 14% that would be
expected if the three models were independent). Note that we seldom
see runs where both dominant and recessive models are significant,
because they lead to opposite patterns of association (Figure 3), but it is
not uncommon to see runs where both additive and recessive, or
additive and dominant models are significant. For simulation code,
see osf.io/4dymh.
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own, because it typically involves gathering information
from tens if not hundreds of thousands of voxels, corre-
sponding to gray or white matter derived variables in the
case of structural imaging (e.g., volume, thickness, ani-
sotropy) or to proxies for underlying neural activity or
connectivity in functional imaging. The spatial and tem-
poral dependencies between voxels need to be taken into
account.
The selection of an ROI is key. The commonest ap-
proach is to do a whole-brain analysis. Some studies in
our review selected specific regions, and some assessed
more than one region: In such cases, it is not sufficient to
do statistical adjustments within the region—one still
needs to treat each region as a new phenotype, with fur-
ther correction applied to take the potential Type I error
inflation into account. The numbers for neuroimaging re-
gions shown in Table 1 refer to the total ROIs that were
considered in the analysis.
For the current analysis, we categorized neuroimaging
articles according to whether they used an ROI specified
a priori on the basis of previous research, with activation
compared between genotype groups within that whole
region. In such a case, it is possible to compare activation
across genotypes to get a realistic effect size. However, as
noted above, where the analysis involves first finding the
voxel or cluster within an ROI that gives peak activation
and then comparing groups, it is not possible to accurate-
ly estimate effect sizes, because the method will capital-
ize on chance and so inflate these. Studies that adopted
this approach are therefore flagged in Figure 1 as giving a
“quasi-effect size.”
Replication Samples
We had originally intended to classify studies according
to whether they included a replication sample, but this
proved inadequate to handle the different approaches
used in our collection of studies. As noted by Clarke
et al. (2011), a true replication uses the same SNPs and
phenotypes as the original study, but in practice replica-
tion studies often depart from such fidelity and may
study nearby variants of the same gene or alternative
measures of the phenotype. We categorized the replica-
tion status of each study as follows:
(a) Study includes a full replication using comparable
genotypes and phenotypes in the discovery and
replication samples. This classification was less
straightforward than it may appear. Consider, for in-
stance, Study 1: The replication sample included the
same SNPs and measures from one of the same
questionnaires as used in the discovery sample,
but with a slightly different subset of items. In gen-
eral, we treated a replication as full provided the
measures were closely similar, so a case such as this
would be regarded as a full replication.
(b) Study includes a partial replication, but with some
variation in genotypes or phenotypes in the discov-
ery and replication samples.
(c) Study is a direct replication of a previous study, so
no replication sample is needed.
(d) Study does not set out to replicate a prior study
(though choice of phenotypes and genotypes is
likely to be influenced by prior work) and does
not include a replication sample.
Even with this classification scheme, categorization
was not always straightforward. For instance, studies that
did not include a replication sample would nevertheless
usually aim to build on prior literature and might repli-
cate previous findings. These were categorized as “prior”
(option b) only if they were explicitly described as aiming
to replicate the earlier work. We anticipated that replica-
tion samples would be more common in journals that
regularly published genetics articles, where the need
for replication is part of the research culture. Table 4
shows the number of articles according to replication
status and journal. Note that there were three journals
in our search for which no articles met our inclusion cri-
teria in the time window we used: Nature Neuroscience,
Neuroimage, and Brain.
Table 3. Correction for Multiple Testing in Relation to whether
Behavioral Phenotypes Are Correlated
NA Correlated
Probably
Correlated Uncorrelated
None 0 2 9 0
Bonferroni 0 1 2 1
Permutation 0 1 0 2
Not needed 11 1a 0 0
aMendelian randomization method.
Table 4. Number of Studies including Replication Sample,
by Journal
Yes Partial Priora No
Annals of Neurology 0 0 0 1
Biological Psychiatry 2 1 0 4
Cerebral Cortex 0 0 0 1
Journal of Cognitive Neuroscience 0 1 0 2
Journal of Neuroscience 0 1 0 2
Molecular Psychiatry 4 1 2 4
Neurology 0 0 0 1
Neuron 0 0 0 1
Pain 1 0 0 1
aStudy explicitly designed to replicate a prior finding.
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Although the numbers are too small to be convincing,
we may note that, in line with expectations, Molecular
Psychiatry, which published the most studies in neuroge-
netics, was the journal with the highest proportion of
studies including a replication, whereas neuroscience
journals that did not have a genetics focus and published
few genetics studies were more likely to publish studies
without any replication sample.
Use of Selected Samples
Some of the studies that we evaluated used samples from
the general population, some used convenience samples,
and some did not clarify how the sample had been re-
cruited. Use of students has been criticized, on the
grounds that people from Western, Educated, Industrial-
ized, Rich, and Democratic (WEIRD) societies are a very
restricted demographic fromwhich tomake generalizations
about human behavior (Henrich, Heine, & Norenzayan,
2010). In the context of genetic research, however, other
serious problems arise from the use of highly selected
samples. Quite simply, if the phenotypic scores of a sample
cover a restricted range, then power to detect genetic
associations can be seriously affected.
We illustrate this with a simulation of an association
between a genetic variant and a phenotype that has an
effect size of r = .2 in the general population. Let us as-
sume that the minor allele frequency is .5, so the ratio of
genotypes aa, aA, and AA in the general population is
1:2:1. Now, suppose we study a sample where everyone
is above average on the phenotype, that is, we only in-
clude those with positive z-scores. As shown in Figure 5,
the effect of genotype on phenotype becomes substan-
tially weaker. If we take an even more extreme group,
that is, the top third of the population, then the effect
is no longer detectable in a moderate-sized sample. As
also shown in Figure 5, as the association between geno-
type and phenotype decreases with selection, the ratio of
the three genotypes changes, because those with the risk
allele are less likely to be included in the sample. In fact,
when there is strong selection, the effect of genotype will
be undetectable, but the frequency of the three geno-
types starts to depart significantly from expected values
(see Figure 6).
A corollary of this effect of sample selection is that
moderate effect sizes in highly selected samples are im-
plausible when the phenotype is related to the criterion
for selection. This is because a moderate effect in a se-
lected group would entail a much larger effect size in
the general population, as well as skewing of the geno-
type distribution in the selected sample. Sample selection
Figure 5. Mean z scores on a
phenotype for three genotypes,
when the true association
between genotype and
phenotype in the population
is r = .2. Data come from
10,000 runs of a simulation.
The left hand panel shows
the association in the full
population; the middle panel
shows means when the sample
is taken only from those in
the top 50% of the population
on the phenotype measure;
and the right-hand panel shows
results when only the top
third of the population is
included. Ns are shown above
the bars. As the selection becomes more extreme, the proportions of each genotype start to depart from the expected 1:2:1 ratio. The script
simulating genopheno cutoffs.R is available on: https://github.com/oscci/SQING_repo.
Figure 6. Relationship between genotype and phenotype depending
on how participants are selected. The −log10 p values of the regression
coefficient (black unfilled circles) are shown for the association
between genotype and phenotype for data simulated as in Figure 5,
depending on whether the analysis is done on the whole population or
a selected subset. The significance of the association decreases as the
selection becomes stricter. The dotted line shows the log p value
corresponding to p = .05. When there is strong selection (inclusion
only of top 33% or 25% of population on a phenotype z score), there is
significant departure from the expected 1:2:1 ratio of genotypes
(as tested by chi-square test, red line).
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is therefore crucial. There may be situations when use of
student samples is acceptable, because student status is
unrelated to the phenotype of interest. However, where
we are studying cognitive phenotypes, we stack the odds
against finding associations with genotypes if we only
study a high-functioning subset of the population. This
can pose problems because, even when efforts are made
to recruit a wide range of participants, those who volun-
teer tend to be biased toward more affluent and educated
people (Rosenthal & Rosnow, 1975).
DISCUSSION
This in-depth analysis of 30 studies from top neurosci-
ence journals complements other evaluations of data
quality that have used text-mining methods to extract in-
formation from larger datasets. The studies varied widely
in methods and phenotypes that were studied, with
some providing good examples of best practice in the
field. Nevertheless, we found that when neuroscience-
oriented journals publish studies that include genetic
analysis, they often fail to adopt the same stringent stan-
dards for sample size and replication as have become
mandatory in the genetics literature.
An important limitation of our analysis is that we eval-
uated only 30 highly heterogeneous studies; it would not
be realistic to assume that the proportion of studies with
specific characteristics is representative of the field as a
whole. Nevertheless, even with this small sample, it is
clear that many genetic studies with neuro or behavioral
phenotypes are underpowered and/or did not correct ad-
equately for multiple testing, even though they were
published in top journals.
Another limitation of our study is that it is based on
just one “selected result” per study, selected as the genet-
ic association with the largest effect size. Many studies ad-
dressed questions that went beyond simple association
between genotype and phenotype. Some considered
the impact of functional groups of genes (e.g., Study 5)
or looked at complex interactions between genetic vari-
ants, brain and behavior phenotypes (e.g., Study 10). A
few complemented studies of humans with animal
models (e.g., Study 11). We note that studies that may
look inconclusive when evaluated purely in terms of
one selected result can compensate for this with converg-
ing evidence from a range of sources, and our analysis is
not sensitive to this.
Despite this limitation of our approach, our analysis
highlighted several issues that may need to be addressed
in order for neurogenetic research to fulfill its promise.
Sample Size and Power
Sample sizes in this area are often too small to detect
likely effects of genetic variation, particularly when neu-
roimaging phenotypes are used. A similar issue was
highlighted for neuroimaging studies in general by
Poldrack et al. (2017), although they noted that sample
sizes are now increasing as awareness of the limitations
of small studies is growing. They concluded that sample
sizes need to be justified by an a priori power analysis.
The problem for researchers is that not only is power
analysis complicated in neuroimaging (Mumford &
Nichols, 2008) but also that these studies are difficult
and time-consuming to conduct and that recruitment of
suitable samples can take months if not years. However,
Poldrack et al. (2017, p. 117) argued: “We do not believe
that the solution is to admit weakly powered studies
simply on the basis that the researchers lacked the
resources to use a larger sample.” Instead, they recom-
mend that, following the example of the field of gen-
etics, researchers need to start working together in
large consortia, so that adequate power can be achieved.
A complementary approach is to preregister a study, so
that hypotheses, methods, and analytic strategy are
decided and are publicly registered before the data are
collected; this can be invaluable in guarding against pub-
lication bias and the dangers of a flexible analytic pipe-
line. Some journals now offer Registered Reports, an
approach where publication of a preregistered study is
offered, conditional on satisfactory reviews and adher-
ence to the preregistered protocol (Chambers, 2013).
An optimistic interpretation of the data in Figure 2 is
that larger effect sizes are seen in smaller studies because
these are studies that use highly specific measures of the
phenotype that are not feasible with large samples. In
particular, there is a widespread belief that neuroimaging
will show stronger genetic effects than behavioral mea-
sures because it is closer to the mechanism of gene ac-
tion. However, a more pessimistic interpretation is that
where large effect sizes are seen in neuroimaging studies
these are likely to be false discoveries arising from the use
of small sample sizes with a very flexible analytic pipeline
and methods that tend to overestimate effect sizes.
Calculation of Effect Size
Our analysis highlighted another problem inherent in
neuroimaging studies: the difficulty of specifying effect
sizes. Lakens (2013) noted that effect size computations
are not only crucial for establishing the magnitude of re-
ported effects but also for creating a literature that is use-
ful for future researchers by providing data in a format
that can be combined with other studies in a meta-
analysis or which can be used to guide power calculations
for future studies. Yet in neuroimaging, this is not stan-
dard. Indeed, only 3 of the 30 studies that we included
explicitly mentioned effect sizes with a conventional in-
terpretation of that term. This is consistent with a system-
atic review by Guo et al. (2014), who found that only 8 of
100 neuroimaging studies reported effect sizes. When re-
ported, effect sizes are typically shown for regions with
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the strongest effects and/or at the maximum voxel,
leading to biased estimates. Correcting for multiple
comparisons analyses further distorts these estimates,
as the strongest voxels will be those with “favorable”
noise (i.e., spurious activity that adds to a true effect).
Correction for Multiple Comparisons
Most studies considered the issue of correction for mul-
tiple comparisons, but few fully corrected for all the tests
conducted, taking into account the number of sub-
groups, genetic models, polymorphisms, and pheno-
types. Researchers appear to be aware of the multiple
testing problem, but there is not one good solution,
and the impression was that sometimes authors thought
they had done enough by applying standard corrections
for fMRI and did not need to correct for other aspects of
the study. For instance, studies looking at correlations
between genotypes or phenotypes in ROI would have
multiple comparisons procedures for whole-brain analy-
ses but would either compute correlations for each ROI
with no control or conversely adopt a Bonferroni correc-
tion (which controls exactly the Type I error rate), which
is known to be overconservative.
In the field of genetics, a range of approaches has been
developed for assessing associations when polymorphisms
are not independent (i.e., in linkage disequilibrium); some
of these, such as methods of data reduction by spectral
decomposition or permutation tests, could be more widely
applied (Clarke et al., 2011). For instance, extraction of
latent factors from correlated phenotypes would provide
a more sensitive approach for identifying genetic associa-
tions, where a range of measures is used to index a partic-
ular construct, such as anxiety or memory.
Replication
Few studies included an independent replication sample,
explicitly separating out the discovery and replication
phases. This approach is now standard in GWAS and
has contributed to the improved reproducibility of find-
ings in that literature. In principle, this is a straight-
forward solution. In practice, however, it requires
additional resources and means that studies take longer
to complete. It also raises the possibility that findings in
the discovery phase will not be replicated, in which case
the overall results may be ambiguous. One solution to
this problem is to apply a more stringent alpha level at
the discovery phase than at the replication phase and
also to present results meta-analyzed across both phases
(Lander & Kruglyak, 1995). However, power calculations
need to take into account the “winner’s curse” phenom-
enon, which refers to the upward biasing of effect sizes
when an original association emerged from a study con-
sidering many variants (Sham & Purcell, 2014).
Completeness of Reporting
An unexpected feature of many of the studies that we an-
alyzed was the difficulty of finding the methodological
information that we required from the published articles.
Because there is no standard format for reporting
methods, it could be difficult to know whether specific
information (e.g., whether phenotypes were correlated)
was simply omitted or whether it might be found in Sup-
plementary Material or figure legends, rather than the
Methods section. Consequently, we had to read studies
many times to find key information.
Most of the journals that we included had stringent
length limits or page charges, which might make it diffi-
cult for authors to report all key information. Exceptions
were Neuroimage, Journal of Neuroscience, Pain, and
Neuron. It is noteworthy that in 2016 Neuron introduced
new guidelines for structured, transparent, accessible re-
porting and removed any length limit on Methods (www.
cell.com/star-methods), with the goal of improving repro-
ducibility of published studies.
Complexity of Analyses
Several studies used complex analytic methods that were
difficult to evaluate, despite the range of disciplinary ex-
pertise covered by the coauthors of our study. This in it-
self is potentially problematic for the field, because it
means that reviewers will either decline to evaluate all
or part of a study or will have to take analyses on trust.
One solution would be for journals to require researchers
to make available all analysis scripts as well as raw data, so
that others could work through the analysis.
Further Considerations
We briefly mention here two additional issues that we
were not able to evaluate systematically in the 30 articles
that we considered but are relevant for future research in
this area.
Validity of Genotype–Phenotype Association
We can be most confident that an association is meaning-
ful if the genetic variant has been shown to be functional,
with physiological effects that relate to the phenotype.
Nevertheless, the ease of demonstrating functionality
is much greater for some classes of variants than others.
Furthermore, an association between an SNP and a phe-
notype does not mean that we have found a functional
polymorphism. Associated SNPs often lie outside genes
andmay be associated with phenotypes only because they
are close to relevant functional variants—what has been
referred to as “indirect genotyping” (Clarke et al., 2011).
Information about such variants can be valuable in provid-
ing landmarks to the key functional variant. With indirect
genotyping, patterns of association may vary depending
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on samples, because different samples may have different
patterns of linkage disequilibrium between genes and
markers. It follows that a failure to replicate does not nec-
essarily mean we have a false positive.
Reliability and Heritability of Phenotypes
The phenotypes that are used in genetic association stud-
ies are increasingly diverse (Flint & Munafò, 2013). The
idea behind the endophenotype concept is that a brain-
based measure will be a more valid measure of the phe-
notypic effect of a genetic variant than other types of
measure, because it is a more direct indicator of a biolog-
ical effect. However, evidence for this assumption is lack-
ing, and the strength of effects will depend on reliability
as well as validity of phenotype measures. Quite simply, if
a measure varies from one occasion of measurement to
another, it is much harder to detect group differences
even if they are real, because there will be noise masking
the true effects. Therefore, it is advisable before embarking
Table 5. Key Information for Neurogenetic Studies
Sample
• Provide a power calculation to determine the sample size. The usual recommendation is for 80% power based on estimated effect size,
which may be based on results with this genetic variant in previous studies. If no prior effect size is available, it is advisable to compute
power with effect size no greater than r= .2, as few common genetic variants have effects larger than this. For neuroimaging studies,
the application Neuropower (Durnez, Degryse, Seurinck, Moerkerke, & Nichols, 2015) is a user-friendly toolbox to help researchers
determine the optimal sample size from a pilot study.
• Give total sample size. Where different numbers are involved at different points in a study, a flowchart is helpful in clarifying the
numbers and reasons for exclusions.
• State how the sample was recruited and whether they are representative of the general population for the phenotype of interest.
Genetic variants
• State how many genetic variants were considered in the analysis.
• List all genetic variants, regardless of whether they gave significant results.
• Give background information indicating what is known about the genetic variants, what is known about the minor allele frequency,
and whether they are functional.
• State whether or not the genetic variants are in linkage disequilibrium, and if so, how this is handled in the analysis.
• State which genetic models were tested and where genotypes are combined, whether this was to achieve a workable sample size or
whether the decision was based on prior research.
Phenotypes
• State whether phenotypes are known to be heritable(e.g., using evidence from twin studies).
• Provide information on the test–retest reliability of the phenotype.
• State whether phenotypes are intercorrelated.
• Neuroimaging phenotypes involved many technical choices affecting the processing pipeline. Guidelines for reporting details of
neuroimaging studies have been developed with the hope of improving reproducibility. The details of analytic information go
beyond the scope of this article, but useful information is given in Box 4 from Poldrack et al. (2017).
Analysis
• State which analyses were planned in advance. Post hoc analyses can be useful, but only if they are clearly distinguished from a priori
hypothesis testing analysis. Where there is a clear a priori hypothesis, consider preregistering the study.
• Describe the total number of independent tests that are conducted on the data. Describe the approach used to deal with multiple
comparisons, bearing in mind that other approaches exist in cases where a Bonferroni correction is likely to be overconservative.
• Make scripts for processing the data openly available on a site such as Github or Open Science Framework. It is common for
authors to describe complex methods that are hard even for experts to understand. By making scripts accessible, authors make
their articles easier to evaluate. Scripts can also serve as a useful training function and facilitate replication.
Results
• Do not rely solely on reporting derived statistics and p values.
• Show measures of central tendency and variation for each genotype group in relation to each phenotype, together with the effect
size, where it is possible to compute this. Where the phenotype is categorical, report the proportions of people with each
genotype who belong in the category.
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on a genetic association study to optimize—or at least
assess—reliability of phenotypic measures. Psychometric
tests typically are designed to take this into account and
data on reliability will be available, but for most experimen-
tal and behavioral measures, this is not the case. Further-
more, indices from functional imaging can vary from time
to time (Nord, Gray, Charpentier, Robinson, & Roiser,
2017), and even structural imaging indices are far from per-
fectly reliable. Further problems occur when applying
methods such as fMRI to the study of individual differences
where people may differ in brain structure or trivial factors,
such as movement in the scanner, masking meaningful
individual variation (Dubois & Adolphs, 2016). As noted
by Carter et al. (2016), neurogenetic studies rely on the as-
sumption that the phenotype is heritable. Yet, for many of
the phenotypes studied in this field, evidence is lacking—
usually because there are no twin studies using that specific
phenotype. Heritability will be limited by reliability: A
measure that shows substantial variation within the
same person from one occasion to the next will not show
good agreement between genetically related individuals.
Proposed Reporting Requirements for
Future Articles
We conclude by making some suggestions that will make
it easier for future researchers to understand neuroge-
netic studies and to combine these in meta-analyses, as
detailed in Table 5. Ultimately, this field may need more
formal reporting guidelines of the kind that have been
designed to improve reproducibility of research in other
areas, such as the guidelines for life sciences research in-
troduced by Nature journals in 2015 (Nature Publishing
Group, 2015) and the COBIDAS guidelines for MRI
(Nichols et al., 2016). Making formal recommendations
is beyond the scope of this article, but we suggest that
if authors systematically reported this basic information
in the Methods section of articles, it would be a major
step forward.
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